Nu Med Plus Stock Price Prediction
| NUMD Stock | USD 0.01 0 10.00% |
Oversold Vs Overbought
40
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Nu Med based on different types of headlines from major news networks to social media. Using Nu Med hype-based prediction, you can estimate the value of Nu Med Plus from the perspective of Nu Med response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Nu Med. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Nu Med to buy its otc stock at a price that has no basis in reality. In that case, they are not buying NUMD because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Nu Med after-hype prediction price | USD 0.01 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
NUMD |
Nu Med After-Hype Price Prediction Density Analysis
As far as predicting the price of Nu Med at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Nu Med or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Nu Med, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Nu Med Estimiated After-Hype Price Volatility
In the context of predicting Nu Med's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Nu Med's historical news coverage. Nu Med's after-hype downside and upside margins for the prediction period are 0.00 and 11.93, respectively. We have considered Nu Med's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Nu Med is out of control at this time. Analysis and calculation of next after-hype price of Nu Med Plus is based on 3 months time horizon.
Nu Med OTC Stock Price Prediction Analysis
Have you ever been surprised when a price of a OTC Stock such as Nu Med is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nu Med backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Nu Med, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.39 | 11.92 | 0.35 | 0.15 | 32 Events / Month | 8 Events / Month | In about 32 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.01 | 0.01 | 20.63 |
|
Nu Med Hype Timeline
Nu Med Plus is now traded for 0.01. The entity has historical hype elasticity of 0.35, and average elasticity to hype of competition of 0.15. NUMD is expected to decline in value after the next headline, with the price expected to drop to 0.01. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -20.63%, whereas the daily expected return is now at -1.39%. The volatility of related hype on Nu Med is about 11310.95%, with the expected price after the next announcement by competition of 0.16. About 62.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.01. Nu Med Plus had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 32 days. Check out Nu Med Basic Forecasting Models to cross-verify your projections.Nu Med Related Hype Analysis
Having access to credible news sources related to Nu Med's direct competition is more important than ever and may enhance your ability to predict Nu Med's future price movements. Getting to know how Nu Med's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Nu Med may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RDGL | Vivos Inc | 0.00 | 0 per month | 0.00 | (0.14) | 10.00 | (8.33) | 23.33 | |
| NSPR | InspireMD | 0.39 | 8 per month | 2.20 | 0.07 | 6.51 | (4.20) | 17.26 | |
| XAIR | Beyond Air | 0.06 | 9 per month | 6.99 | 0.04 | 10.53 | (10.00) | 36.74 | |
| OPGN | OpGen Inc | 0.00 | 0 per month | 0.00 | (0.13) | 7.05 | (12.02) | 39.12 | |
| EMED | Electromedical Technologies | 0.00 | 0 per month | 11.64 | 0.03 | 33.33 | (25.00) | 73.33 | |
| BIEL | Bioelectronics Corp | 0.00 | 0 per month | 12.62 | 0.1 | 50.00 | (33.33) | 83.33 | |
| VVOS | Vivos Therapeutics | (0.04) | 6 per month | 3.96 | 0.15 | 9.43 | (6.90) | 19.92 | |
| MXCT | MaxCyte | (0.06) | 10 per month | 3.40 | (0) | 5.31 | (5.75) | 18.57 | |
| ASXC | Asensus Surgical | 0.00 | 10 per month | 2.17 | 0.11 | 4.35 | (4.17) | 55.98 | |
| DXCM | DexCom Inc | 0.64 | 11 per month | 1.54 | 0.07 | 4.17 | (2.58) | 10.13 | |
| TNDM | Tandem Diabetes Care | 0.38 | 10 per month | 0.00 | (0.08) | 6.14 | (6.23) | 14.41 | |
| PACB | Pacific Biosciences of | (0.23) | 9 per month | 5.87 | 0.02 | 11.96 | (10.16) | 41.72 | |
| NNOX | Nano X Imaging | 0.23 | 6 per month | 4.16 | 0.04 | 6.35 | (7.67) | 35.93 |
Nu Med Additional Predictive Modules
Most predictive techniques to examine NUMD price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for NUMD using various technical indicators. When you analyze NUMD charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Nu Med Predictive Indicators
The successful prediction of Nu Med stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Nu Med Plus, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Nu Med based on analysis of Nu Med hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Nu Med's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Nu Med's related companies.
Story Coverage note for Nu Med
The number of cover stories for Nu Med depends on current market conditions and Nu Med's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Nu Med is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Nu Med's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Nu Med Short Properties
Nu Med's future price predictability will typically decrease when Nu Med's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Nu Med Plus often depends not only on the future outlook of the potential Nu Med's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nu Med's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 79.3 M | |
| Shares Float | 27.7 M |
Complementary Tools for NUMD OTC Stock analysis
When running Nu Med's price analysis, check to measure Nu Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Med is operating at the current time. Most of Nu Med's value examination focuses on studying past and present price action to predict the probability of Nu Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Med's price. Additionally, you may evaluate how the addition of Nu Med to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |